TheProfitWatch

TNGX - Tango Therapeutics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.9 1.05 (11.74%) -0.02 (-0.15%) -0.05 (-0.55%) 0.13 (1.27%) -0.37 (-4.16%) 1.33 (15.37%) 0.1 (1.15%) -0.37 (-4.14%)

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.35
Diluted EPS:
-0.35
Basic P/E:
-28.4143
Diluted P/E:
-28.4143
RSI(14) 1m:
72.81
VWAP:
9.96
RVol:

Events

Period Kind Movement Occurred At

Related News